Month: November 2011

  • By Sherri Oslick — About Court Report:  Each week we will report briefly on recently filed biotech and pharma cases. Cephalon Inc. et al. v. Mylan Pharmaceuticals Inc. et al.1:11-cv-01111; filed November 9, 2011 in the District Court of Delaware • Plaintiffs:  Cephalon Inc.; CIMA Labs Inc.• Defendants:  Mylan Pharmaceuticals Inc.; Mylan Inc. Infringement of…

  • November 14, 2011 – Global Perspectives on the Role of Intellectual Property Rights in Innovation and Development (The World Bank) – Washington, DC November 15, 2011 – Patent Reform: First to File Provisions (Strafford) – 1:00 – 2:30 pm (EST) November 16, 2011 – The Leahy Smith America Invents Act: Implementation and Implications (Intellectual Property…

  • The Intellectual Property Owners Association (IPO) and U.S. Patent and Trademark Office will be co-sponsoring the 22nd Annual Conference on USPTO Law and Practice (PTO Day) on December 5, 2011 in Washington, D.C.  The PTO Day program includes patent general sessions on the following topics: • PTO Year in Review and in depth look at…

  • The Intellectual Property Law Association of Chicago (IPLAC) and the Center for Intellectual Property Law and Information Technology at DePaul College of Law will be offering a town hall lecture on The Leahy Smith America Invents Act: Implementation and Implications on November 16, 2011 from 12:00 to 1:30 pm (CT) at the DePaul Center in…

  • Law Education Institute, Inc. (LEI) will be holding the 29th Annual National CLE Conference on January 4-8, 2012 in Snowmass, Colorado.  The Intellectual Property program of the conference will offer presentations on a number of topics, including: • Using Legislation to Protect IP• Joint Infringement: Offensive and Defensive Considerations• Crucial Issues Concerning Induced and Contributory…

  • By James DeGiulio — Earlier this year, we reported on the fading interest among larger pharmaceutical companies in developing new antibiotics, despite drug-resistant bacteria representing a serious public health issue (see "Increase in Drug-Resistant Bacteria Creating Need for New Antibiotics").  On October 19, Senators Richard Blumenthal (D-CT) (at right) and Bob Corker (R-TN) (below left)…

  • By Donald Zuhn — Today, the Federal Circuit affirmed the denial by the District Court for the Eastern District of Virginia of Plaintiff-Appellant M.R. Mikkilineni's motion under Fed. R. Civ. P. 60(b)(3) requesting relief from a final judgment due to alleged fraud by the U.S. Patent and Trademark Office.  In denying the motion, the Federal…

  • By Donald Zuhn — In an appeal decided last month, the Federal Circuit reversed a decision by the District Court for the Southern District of New York awarding prejudgment interest to Plaintiffs-Appellees Sanofi-Aventis, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership ("Sanofi"); affirmed the District Court's denial of a motion for leave to file…

  • By Kevin E. Noonan — Commissioner for Patents Robert Stoll and Patent Reform Coordinator Janet Gongola were featured speakers at last week's BIO's Intellectual Property Counsels Committee (BIO IPCC) meeting and both (as expected) focused much of their remarks on the Leahy-Smith America Invents Act.  Insofar as portions of both officials' talks reviewed the provisions…

  • By Donald Zuhn — Commissioner Stoll to Retire from Government Service On Wednesday, the U.S. Patent and Trademark office announced that Commissioner of Patents Robert Stoll (at right) would be retiring from the agency effective December 31, 2011.  The Office also announced that Director David Kappos will nominate current Deputy Commissioner for Patents Margaret "Peggy"…